David Patience - 26 Feb 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Signature
/s/ David Patience
Issuer symbol
AXDX
Transactions as of
26 Feb 2024
Net transactions value
-$336
Form type
4
Filing time
27 Feb 2024, 18:59:40 UTC
Previous filing
25 Jan 2024
Next filing
06 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +1,000 +3.9% $0.000000 26,597 26 Feb 2024 Direct F1
transaction AXDX Common Stock Sale $336 -350 -1.3% $0.9600 26,247 26 Feb 2024 Direct F2
holding AXDX Common Stock 760 26 Feb 2024 By Spouse IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -1,000 -40% $0.000000 1,500 26 Feb 2024 Common Stock 1,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units ("RSUs"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.